The proportion of eyes showing an improvement of visual acuity by 10 letters on a LogMAR chart compared with the pre-injection level 24 months after treatment 24 month [clinicaltrials_resource:9159b2cc43f766dac3b6046c3b491ea4]
At 24 months, improvement of ≥10 LogMAR letters was seen in 15/42 (36%) eyes treated with IVTA plus laser compared with 7/42 (17%) eyes treated with laser only (p=0.047, odds ratio 2.79, 95% CI, 1.01, 7.67).
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
The proportion of eyes showing an improvement of visual acuity by 10 letters on a LogMAR chart compared with the pre-injection level 24 months after treatment 24 month [clinicaltrials_resource:9159b2cc43f766dac3b6046c3b491ea4]
At 24 months, improvement of ≥10 LogMAR letters was seen in 15/42 (36%) eyes treated with IVTA plus laser compared with 7/42 (17%) eyes treated with laser only (p=0.047, odds ratio 2.79, 95% CI, 1.01, 7.67).
Bio2RDF identifier
9159b2cc43f766dac3b6046c3b491ea4
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:9159b2cc43f766dac3b6046c3b491ea4
measure [clinicaltrials_vocabulary:measure]
The proportion of eyes showing ...... evel 24 months after treatment
time frame [clinicaltrials_vocabulary:time-frame]
description
At 24 months, improvement of ≥ ...... tio 2.79, 95% CI, 1.01, 7.67).
identifier
clinicaltrials_resource:9159b2cc43f766dac3b6046c3b491ea4
title
The proportion of eyes showing ...... onths after treatment 24 month
@en
type
label
The proportion of eyes showing ...... 9b2cc43f766dac3b6046c3b491ea4]
@en